Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Concert Pharmaceuticals, Inc. (CNCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.9100-0.0200 (-0.68%)
At close: 04:00PM EST
2.8800 -0.03 (-1.03%)
After hours: 04:41PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.9300
Open2.9700
Bid2.7000 x 1800
Ask2.9600 x 900
Day's Range2.8800 - 3.0500
52 Week Range2.6400 - 11.0400
Volume49,453
Avg. Volume859,626
Market Cap100.86M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CNCE

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Concert Pharmaceuticals, Inc.
    ENTA: Lowering target price to $66.00ENANTA PHARMACEUTICALS INC has an Investment Rating of BUY; a target price of $66.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
All
News
Press Releases
Advertisement
Advertisement